We are live on ! Find out more
APTO

Aptose Biosciences, Inc.
APTO

Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

20 hedge funds and large institutions have $5.91M invested in Aptose Biosciences, Inc. in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

83% more capital invested

Capital invested by funds: $3.23M → $5.91M (+$2.68M)

18% more funds holding

Funds holding: 17 → 20 (+3)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
3
Reduced
5
Closed
2
Calls
$22K
Puts
–
Net Calls
+$22K
Net Calls Change
-$47K

Top Buyers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
+$4.93M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$38.4K
3
NFG
Noven Financial Group
Colorado
+$30.5K
4
UBS Group
UBS Group
Switzerland
+$24.6K
5
PFGIA
Patriot Financial Group Insurance Agency
Massachusetts
+$12.8K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$477K
2
Deutsche Bank
Deutsche Bank
Germany
-$365K
3
Morgan Stanley
Morgan Stanley
New York
-$111K
4
Citadel Advisors
Citadel Advisors
Florida
-$64.9K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$30.5K

APTO Hedge Fund Activity: Q4 2018 in Review

20 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q4 2018, worth a combined $5.91M — up 83% from $3.23M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new APTO positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 5 trimmed.

The largest buyer was DRW Securities, adding an estimated $4.93M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $477K sold.

  • 20 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q4 2018, up from 17 in Q3 2018.
  • Funds reported $5.91M of Aptose Biosciences, Inc. stock for Q4 2018, up 83% quarter-over-quarter.
  • 5 funds opened new Aptose Biosciences, Inc. positions in Q4 2018 and 2 closed out, a net change of +3 holders.
  • The largest Aptose Biosciences, Inc. buyer in Q4 2018 was DRW Securities, an estimated $4.93M added.
  • The largest Aptose Biosciences, Inc. seller in Q4 2018 was Renaissance Technologies, an estimated $477K sold.

Based on aggregated 13F filings for Q4 2018.